NDT Advance Access published online on September 17, 2007
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfm244
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Influence of cytokine gene polymorphisms on erythropoetin dose requirements in chronic haemodialysis patients
1Medical Department IV, University of the Saarland, Homburg/Saar, Germany, 2Division of Renal Medicine, Department of Clinical Science Intervention and Technology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden and 3Medical Department I, Klinikum Deggendorf, Deggendorf, Germany
Correspondence and offprint requests to: Matthias Girndt, Medical Department IV, Nephrology and Hypertension Unit, University of the Saarland, D-66421 Homburg/Saar, Germany. Email: matthias.girndt{at}uks.eu
 |
Abstract |
|---|
Background. Chronic inflammation influences renal anaemia and reduce erythropoetin effectiveness. Chronic kidney disease and haemodialysis (HD) induce elevated cytokine and C-reactive protein (CRP) levels at an inter-individually variable extent. These differences are in part due to polymorphisms within cytokine genes, e.g. for pro-inflammatory interleukin-6 (IL-6) and anti-inflammatory interleukin-10 (IL-10). We hypothesized that these polymorphisms influence erythropoetin effectiveness.
Methods. Genotyping for polymorphisms of IL-6 (–174G/C) and IL-10 (–1082G/A) genes was done in 460 prevalent HD patients. Erythropoetin requirements were determined after three months of stable dosing of erythropoesis stimulating proteins (ESP). The effect of the cytokine genotypes was evaluated by multiple regression analysis.
Results. The presence of the IL-6 –174G allele (found to be related with higher secretion of IL-6) was associated with a 26% higher ESP dose compared with individuals without the G allele (P = 0.008). The IL-10 –1082 G/A polymorphism was not associated with ESP needs. Multivariate analysis detected a predictive value for ESP dose of the IL-6 polymorphism (P = 0.022), the haemoglobin level and the dose of i.v. iron, but not of age, gender, dialysis vintage, ferritin or the CRP value.
Conclusions. Presence of the IL-6 allele –174G is related to higher ESP doses in chronic HD patients. The polymorphism of the anti-inflammatory IL-10 does not influence ESP dose, probably due to the fact that this cytokine has directly inhibitory effects on haematopoiesis in addition to its beneficial effects on inflammation.
Keywords: cytokines; erythropoetin; haemodialysis; inflammation; kidney failure chronic; polymorphism genetic
Received for publication: 2. 1.07
Accepted in revised form: 30. 3.07
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. L. M. de Francisco, P. Stenvinkel, and S. Vaulont Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness NDT Plus, January 1, 2009; 2(suppl_1): i18 - i26. [Abstract] [Full Text] [PDF]
|
|